These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7514641

  • 21. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA.
    Nature; 1990 Jul 12; 346(6280):183-7. PubMed ID: 1694970
    [Abstract] [Full Text] [Related]

  • 22. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN, Chou YK, Whitham RH, Buckner J, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA.
    J Immunol; 1998 Jul 15; 161(2):1034-44. PubMed ID: 9670985
    [Abstract] [Full Text] [Related]

  • 23. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M, Ristori G, D'Amato M, Buttinelli C, Falcone M, Fieschi C, Wekerle H, Pozzilli C.
    Eur J Immunol; 1993 Jun 15; 23(6):1232-9. PubMed ID: 7684682
    [Abstract] [Full Text] [Related]

  • 24. T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes.
    Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT.
    Eur J Immunol; 1989 Feb 15; 19(2):279-84. PubMed ID: 2467813
    [Abstract] [Full Text] [Related]

  • 25. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L.
    J Clin Invest; 1993 Feb 15; 91(2):616-28. PubMed ID: 7679413
    [Abstract] [Full Text] [Related]

  • 26. Preferential but not exclusive T cell receptor V beta chain utilization of myelin basic protein and peptide-specific T cell clones in mice.
    Kalman B, Knobler RL, Lublin FD.
    Cell Immunol; 1994 Jan 15; 153(1):206-13. PubMed ID: 7507001
    [Abstract] [Full Text] [Related]

  • 27. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition.
    Hausmann S, Martin M, Gauthier L, Wucherpfennig KW.
    J Immunol; 1999 Jan 01; 162(1):338-44. PubMed ID: 9886404
    [Abstract] [Full Text] [Related]

  • 28. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity.
    Jingwu Z, Medaer R, Hashim GA, Chin Y, van den Berg-Loonen E, Raus JC.
    Ann Neurol; 1992 Sep 01; 32(3):330-8. PubMed ID: 1384421
    [Abstract] [Full Text] [Related]

  • 29. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.
    Nat Genet; 1999 Nov 01; 23(3):343-7. PubMed ID: 10610182
    [Abstract] [Full Text] [Related]

  • 30. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
    Huh J, Yao K, Quigley L, Ludwin SK, McFarland HF, Muraro PA, Martin R, Ito K.
    J Neuroimmunol; 2004 Jun 01; 151(1-2):94-102. PubMed ID: 15145608
    [Abstract] [Full Text] [Related]

  • 31. Identification of autoimmune T cells among in vivo expanded CD25+ T cells in multiple sclerosis.
    Illés Z, Kondo T, Yokoyama K, Ohashi T, Tabira T, Yamamura T.
    J Immunol; 1999 Feb 01; 162(3):1811-7. PubMed ID: 9973446
    [Abstract] [Full Text] [Related]

  • 32. Highly restricted TCR-alpha beta usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope.
    Kuwana M, Medsger TA, Wright TM.
    J Immunol; 1997 Jan 01; 158(1):485-91. PubMed ID: 8977226
    [Abstract] [Full Text] [Related]

  • 33. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
    Vergelli M, Hemmer B, Utz U, Vogt A, Kalbus M, Tranquill L, Conlon P, Ling N, Steinman L, McFarland HF, Martin R.
    Eur J Immunol; 1996 Nov 01; 26(11):2624-34. PubMed ID: 8921948
    [Abstract] [Full Text] [Related]

  • 34. Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
    De Keyser F, Elewaut D, Overmeer-Graus JP, Van den Broek P, Rijnders AW, Veys EM.
    J Rheumatol; 1997 Sep 01; 24(9):1685-9. PubMed ID: 9292788
    [Abstract] [Full Text] [Related]

  • 35. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y, Li H, Martin R, Mariuzza RA.
    J Mol Biol; 2000 Nov 24; 304(2):177-88. PubMed ID: 11080454
    [Abstract] [Full Text] [Related]

  • 36. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules.
    Chou YK, Vainiene M, Whitham R, Bourdette D, Chou CH, Hashim G, Offner H, Vandenbark AA.
    J Neurosci Res; 1989 Jun 24; 23(2):207-16. PubMed ID: 2474079
    [Abstract] [Full Text] [Related]

  • 37. T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects.
    Liblau R, Tournier-Lasserve E, Maciazek J, Dumas G, Siffert O, Hashim G, Bach MA.
    Eur J Immunol; 1991 Jun 24; 21(6):1391-5. PubMed ID: 1710565
    [Abstract] [Full Text] [Related]

  • 38. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.
    Bourdette DN, Whitham RH, Chou YK, Morrison WJ, Atherton J, Kenny C, Liefeld D, Hashim GA, Offner H, Vandenbark AA.
    J Immunol; 1994 Mar 01; 152(5):2510-9. PubMed ID: 7510746
    [Abstract] [Full Text] [Related]

  • 39. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 40. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
    Zhu X, Zhu P, Guo XL.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3316-22. PubMed ID: 16409835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.